Stay updated on Immunotherapy Combinations in Gastric Cancers Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Combinations in Gastric Cancers Clinical Trial page.

Latest updates to the Immunotherapy Combinations in Gastric Cancers Clinical Trial page
- ChecktodayChange DetectedAn NIH-wide banner announces a terminology change from “Artificial Intelligence” to “Super Intelligence” and links to transition updates and FAQs.SummaryDifference1%

- Check7 days agoChange DetectedThe footer’s site revision label changes from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedThe site’s displayed revision label changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check35 days agoChange DetectedThe MORPHEUS study page now shows a 403 Forbidden error instead of the study details, effectively restricting access to the trial information and related navigation on ClinicalTrials.gov.SummaryDifference24%

- Check56 days agoChange DetectedThe page metadata now includes the NIH grant/contract year 2016. The documentation revision has been updated to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check77 days agoChange DetectedThe Morpheus-Gastric and Esophageal Cancer trial is terminated with results posted and 219 participants enrolled; new sites in Seoul National University Hospital and National Taiwan University Hospital in Taipei are now listed.SummaryDifference2%

Stay in the know with updates to Immunotherapy Combinations in Gastric Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Combinations in Gastric Cancers Clinical Trial page.